Difficulties in screening and diagnosis prostate cancer: an integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i8.31213

Keywords:

Prostatic Neoplasms; Mass Screening; Diagnosis.

Abstract

In Brazil, Prostate Cancer (PCa) is the second most common in men and has a high rate of morbidity and mortality. Therefore, the importance of early screening from the age of 50 is recommended. Given that, this study aims to analyze the screening and diagnosis difficulties encountered in Primary Health Care (PHC) for PCa prevention. This is an integrative literature review study, with a search performed mutually by two researchers in the Virtual Health Library (VHL), Scielo and PubMed, by crossing the descriptors “prostate cancer”, “screening” and “diagnosis”, using the Boolean operator and. To carry out the search and selection of articles, the following elegibility criteria were used: productions from the last two years; fully available for free; and published in Portuguese, English and Spanish. The initial search resulted in 488 articles, of which 105 met the adopted eligibility criteria. Of those, excluded the duplications, seven were selected to compose the corpus of the review because they meet the objective of the study. It was possible to identify factors that make it difficult for men to make a decision to perform PCa screening and diagnosis, especially beliefs, male self-vulnerability and medical communication. Besides, differences were found among health professionals about the standardization of criteria for screening. We emphasize the need for constant research in order to identify the difficulties of PCa screening and diagnosis.

References

Aquino, R. C. A. & Rodrigues, M. (2016). Acesso e itinerário terapêutico dos pacientes com câncer: principais dificuldades enfrentadas para este percurso. Saúde.com, 12 (1), 488-496.

Belinelo, R. G. S., Almeida, S. M., Oliveira, P. P., Onofre, P. S. C., Viegas, S. M. F. & Rodrigues, A. B. (2014). Exames de rastreamento para o câncer de próstata: vivência de homens. Esc Anna Nery, 18 (4), 697-704.

Booven D. J. V., Kuchakulla, M., Pai, R. Frech, F. S., Ramasahayam, R., Reddy, P., Parmar, M., Ramasamy, R. & Arora, H. (2021). A Systematic Review of Artificial Intelligence in Prostate Cancer. Res Rep Urol, 13, 31-39.

Brasil. Ministério da Saúde. (2008). Política Nacional de Atenção Integral à Saúde do Homem. Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 (6), 394-424.

Choi, J.B., Myong, J.P., Lee Y., Kim, I., Kim, J. H., Hong, S. H. & Ha, U. S. (2020). Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference. BMC Cancer, 20 (1), 589-596.

Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A. & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer, 144 (8), 1941-1953.

Heijnsdijk E. A. M., Gulati, R., Tsodikov, A., Lange, J. M., Mariotto, A. B., Vickers, A. J., Carlsson, S. V. & Etzioni, R. (2020). Lifetime Benefits and Harms of Prostate-Specific Antigen-Based Risk-Stratified Screening for Prostate Cancer. J Natl Cancer Inst, 112 (10), 1013-1020.

Instituto Nacional de Câncer José Alencar Gomes da Silva. (2019). Estimativa 2020: incidência de câncer no Brasil. INCA.

Kantoff, P., Taplin, M. E., Smith, J. A., Vogelzang, N., Lee, W. R. Richie, J. P. & Givens, J. (2020). Clinical presentation and diagnosis of prostate cancer. UpToDate.

Kumar, V., Abbas, A. K., Fausto, N., Aster, J. C. (2010). Robbins & Cotran Patologia: Bases Patológicas das Doenças. Elsevier.

Moreira, R. L. S. F., Fontes, W. D. & Barboza, T. M. Dificuldades de inserção do homem na atenção básica a saúde: a fala dos enfermeiros. (2014). Esc Anna Nery, 18 (4), 615-621.

Oliveira, P. S. D., Miranda, S. V. C., Barbosa, H. A., Rocha, R. M. B., Rodrigues, A. B. & Silva, V. M. (2019). Cáncer de próstata: conocimientos e interferencias en la promoción y prevención de la enfermedad. Enferm Glob, 18 (2), 250-261.

Opondo, C.O., Onyango, P. O., Asweto, C.O. (2022). Effect of perceived self-vulnerability on prostate cancer screening uptake and associated factors: a cross-sectional study of public health facilities in western Kenya. Ann Glob Health, 88, (1) 1-12.

Porto, C. C. (2009). Semiologia Médica. Guanabara Koogan.

Sadi, M. V. (2017). PSA screening for prostate cancer. Rev Assoc Med Bras, 63 (8), 722-725.

Santos, R. O. M. D., Abreu, M. M., Migowski, A.; Engstrom, E. M. (2022). Decision aid for prostate cancer screening in Brazil. Rev Saúde Pública, 56 (19).

Sartor, O. (2021). Risk factors for prostate cancer. UpToDate.

Separavich, M. A.; Canesqui, A. M. (2013). Saúde do homem e masculinidades na Política Nacional de Atenção Integral à Saúde do Homem: uma revisão bibliográfica. Saúde Soc, 22 (2), 415-428.

Shungu, N. & Sterba, K. R. (2021). Barriers and facilitadors to informed decision-making about prostate cancer screening among black men. J Am Board Fam Med, 34 (5), 925-936.

Silva, P. R. V. & Jorge, T. C. A. (2021). Ciclos de interesse coletivo e tendências das buscas no Google relacionadas a campanhas institucionais sobre o câncer de próstata: promovendo saúde ou doenças? Ciência & Saúde Coletiva, 26 (2), 3517-3525.

Tortora, G. J. & Derrickson, B. (2019). Princípios de Anatomia e Fisiologia. Guanabara Koogan.

Published

26/06/2022

How to Cite

MOREIRA, L. A.; GUIMARÃES, M. B. .; ANDRADE, A. R. O. de .; ARAÚJO, T. de S. L.; MARQUES, G. A. R. .; VAL , J. C. S. M. G. . Difficulties in screening and diagnosis prostate cancer: an integrative review. Research, Society and Development, [S. l.], v. 11, n. 8, p. e48011831213, 2022. DOI: 10.33448/rsd-v11i8.31213. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/31213. Acesso em: 22 nov. 2024.

Issue

Section

Health Sciences